Literature DB >> 6997997

Current status of ventilation-perfusion imaging.

R D Neumann, H D Sostman, A Gottschalk.   

Abstract

The major clinical use of ventilation-perfusion (V/Q) scintigraphy is for the diagnosis of pulmonary embolism (PE). Accurate diagnosis of PE is essential since effective treatment is available but involves some risk to the patient. The scintigraphic characteristics of PE are segmental perfusion defects in lung that is normally ventilated and normal on the radiograph. The inherent shortcoming of perfusion scintigraphy is its lack of specificity. Combining a ventilation study with perfusion imaging improves the diagnostic specificity of lung scintigraphy. Xenon-133 is currently the most commonly used radionuclide for routine ventilation studies; a long washout technique is more sensitive than single-breath imaging when this radionuclide is used. We obtain preperfusion xenon-133 ventilation studies with a 4-min rebreathing equilibrium phase and a long 5-min washout phase to obtain maximum information. It is imperative that V/Q studies be interpreted with a current high quality chest radiograph. Interpretation of V/Q studies for PE is perhaps best done by assigning a probability diagnosis, since rarely is absolute specificity possible. This article details the criteria we use for these probability determinations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6997997     DOI: 10.1016/s0001-2998(80)80002-x

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  9 in total

1.  Emission tomography in embolic lung disease.

Authors:  R M Donaldson; O Khan; J G Bennett; P J Ell
Journal:  Tex Heart Inst J       Date:  1982-06

2.  Chest imaging.

Authors:  N L Müller
Journal:  Can Fam Physician       Date:  1986-05       Impact factor: 3.275

3.  99mTc particle perfusion/99mTc aerosol ventilation imaging using a subtraction technique in suspected pulmonary embolism.

Authors:  L Pöyhönen; V Turjanmaa; A Virjo
Journal:  Eur J Nucl Med       Date:  1985

4.  Use of radiopharmaceuticals in diagnostic nuclear medicine in the United States: 1960-2010.

Authors:  Vladimir Drozdovitch; Aaron B Brill; Ronald J Callahan; Jeffrey A Clanton; Allegra DePietro; Stanley J Goldsmith; Bennett S Greenspan; Milton D Gross; Marguerite T Hays; Stephen C Moore; James A Ponto; Walton W Shreeve; Dunstana R Melo; Martha S Linet; Steven L Simon
Journal:  Health Phys       Date:  2015-05       Impact factor: 1.316

5.  Reporting of ventilation perfusion images for pulmonary embolism: accuracy and precision.

Authors:  H W Gray; D W Pearson; F Moran; R G Bessent
Journal:  Eur J Nucl Med       Date:  1984

6.  Single photon emission computed tomography of the lung: preliminary results.

Authors:  H J Biersack; H Altland; R Knopp; C Winkler
Journal:  Eur J Nucl Med       Date:  1982

7.  Plasma DNA in the diagnosis of pulmonary embolism.

Authors:  W R Breitwieser; C W Hartman; W S Morris; M K Fleetwood; J A Baxter; R E Albertini
Journal:  Thorax       Date:  1983-03       Impact factor: 9.139

8.  81mKr gas and 99mTc-MAA V/Q ratio images for detection of V/Q mismatches.

Authors:  E L Kramer; J J Sanger
Journal:  Eur J Nucl Med       Date:  1984

9.  Ventilation-perfusion scintigram in diabetics.

Authors:  K Uchida; K Takahashi; R Aoki; T Ashitaka
Journal:  Ann Nucl Med       Date:  1991-09       Impact factor: 2.668

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.